S
Sanjeev Meena
Researcher at Central Drug Research Institute
Publications - 38
Citations - 763
Sanjeev Meena is an academic researcher from Central Drug Research Institute. The author has contributed to research in topics: Cancer cell & Cancer. The author has an hindex of 13, co-authored 33 publications receiving 604 citations. Previous affiliations of Sanjeev Meena include Academy of Scientific and Innovative Research & Council of Scientific and Industrial Research.
Papers
More filters
Journal ArticleDOI
Tumor heterogeneity and cancer stem cell paradigm: updates in concept, controversies and clinical relevance.
Anup Kumar Singh,Rakesh K. Arya,Shrankhla Maheshwari,Shrankhla Maheshwari,Akhilesh Singh,Sanjeev Meena,Priyanka Pandey,Olivier Dormond,Dipak Datta,Dipak Datta +9 more
TL;DR: A path-breaking chapter was added to this saga when three independent groups reported the in vivo existence of cancer stem cells (CSCs) in brain, skin and intestinal tumors using lineage-tracing and thus strengthened the CSC concept.
Journal ArticleDOI
Antiproliferative Action of Xylopia aethiopica Fruit Extract on Human Cervical Cancer Cells
Oluwatosin A. Adaramoye,Jayanta Sarkar,Neetu Singh,Sanjeev Meena,Bendangla Changkija,Prem P. Yadav,Sanjeev Kanojiya,Sudhir Sinha +7 more
TL;DR: Results indicate that XAFE could be a potential therapeutic agent against cancer since it inhibits cell proliferation, and induces apoptosis and cell cycle arrest in C‐33A cells.
Journal ArticleDOI
Synthesis and cytotoxicity evaluation of (tetrahydro-β-carboline)-1,3,5-triazine hybrids as anticancer agents
Ravi Kumar,Leena Gupta,Pooja Pal,Shahnawaz Khan,Neetu Singh,Sanjay Babu Katiyar,Sanjeev Meena,Jayanta Sarkar,Sudhir Sinha,Jitendra Kumar Kanaujiya,Savita Lochab,Arun Kumar Trivedi,Prem M. S. Chauhan +12 more
TL;DR: A series of tetrahydro-beta-carbolines and 1,3,5-triazine hybrids synthesized and evaluated for their cytotoxicity against a panel of eight human cancer cell lines and normal human fibroblasts led to discovery of racemic compounds 69, 71 and 75, which are selectively cytotoxic towards KB cell line.
Journal ArticleDOI
Isolation, Characterization and Anticancer Potential of Cytotoxic Triterpenes from Betula utilis Bark.
Tripti Mishra,Rakesh K. Arya,Sanjeev Meena,Pushpa Joshi,Mahesh Pal,Baleshwar Meena,Dalip K. Upreti,Tikam Singh Rana,Dipak Datta +8 more
TL;DR: Novel source of UA having potent tumor cell specific cytotoxic property is discovered, indicating its therapeutic potential against breast cancer.
Journal ArticleDOI
Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells
Shikha S. Chauhan,Shikha S. Chauhan,Anup Kumar Singh,Sanjeev Meena,Minaxi B. Lohani,Akhilesh Singh,Rakesh K. Arya,Srikanth H. Cheruvu,Jayanta Sarkar,Jiaur R. Gayen,Dipak Datta,Prem M. S. Chauhan +11 more
TL;DR: A series of novel β-carboline based chalcones was synthesized and evaluated for their cytotoxic activity against a panel of human cancer cell lines and found that two of the compounds, 7c and 7d, showed marked anti-proliferative activity in aPanel of solid tumor cell lines with highest effect in breast cancer.